David G. Tew

5.3k citations

57 papers · 4.2k indexed · 2 hit papers · h-index 30

Co-authors: Valerie B. O’Donnell Owen Jones P. England Christopher Southan David J. Powell P.R. Ortiz de Montellano Thomas D. Meek Colin H. Macphee
Topics: Protease and Inhibitor Mechanisms (6 papers)Pharmacogenetics and Drug Metabolism (4 papers)Electrochemical Analysis and Applications (4 papers)
Cited by: Physiology Cancer Research Pharmacology
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry Nature Communications
Partner nations: United Kingdom United States Spain

In The Last Decade

David G. Tew

57 papers receiving 4.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Identification of a Novel Aspartic Protease (Asp 2) as β-Secretase

1999 887 citations Ishrut Hussain, David J. Powell et al. Molecular and Cellular Neuroscience profile →
Studies on the inhibitory mechanism of iodonium compounds with special reference to neutrophil NADPH oxidase

1993 518 citations David G. Tew et al. profile →

Peers

Countries citing papers authored by David G. Tew

Since Specialization

Citations

This map shows the geographic impact of David G. Tew's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David G. Tew with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David G. Tew more than expected).

Fields of papers citing papers by David G. Tew

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David G. Tew. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David G. Tew. The network helps show where David G. Tew may publish in the future.

Co-authorship network of co-authors of David G. Tew

This figure shows the co-authorship network connecting the top 25 collaborators of David G. Tew. A scholar is included among the top collaborators of David G. Tew based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David G. Tew. David G. Tew is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Differential sensing with arrays of de novo designed peptide assemblies 2023 ·Nature Communications ·William Dawson,Kathryn L. Shelley,Jordan M. Fletcher,(unknown),Lucia Lombardi,Guto G. Rhys,(unknown),(unknown),Antony J. Burton,Jessica A. Cross,(unknown),(unknown),(unknown),R.L. Brady,David G. Tew,Christopher W. Wood,Derek N. Woolfson	24
2	Improved betulinic acid biosynthesis using synthetic yeast chromosome recombination and semi-automated rapid LC-MS screening 2020 ·Nature Communications ·(unknown),(unknown),David Bell,(unknown),Marcelo Kern,David G. Tew,David McClymont,Tom Ellis	57
3	Decorating Self-Assembled Peptide Cages with Proteins 2017 ·ACS Nano ·James F. Ross,Angela Bridges,Jordan M. Fletcher,Deborah K. Shoemark,Dominic Alibhai,(unknown),(unknown),William Dawson,Lorna Hodgson,Judith Mantell,Paul Verkade,C. Edge,Richard B. Sessions,David G. Tew,Derek N. Woolfson	52
4	Amino acid anthranilamide derivatives as a new class of glycogen phosphorylase inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Karen A. Evans,(unknown),Frank T. Coppo,Todd L. Graybill,(unknown),Mehul Patel,Jennifer Gale,Hu Li,Sara H. Thrall,David G. Tew,Francis X. Tavares,Stephen A. Thomson,James E. Weiel,Joyce A. Boucheron,(unknown),Andrea H. Epperly,Pamela L. Golden	9
5	Utilization of Substrate-Induced Quenching for Screening Targets Promoting NADH and NADPH Consumption 2006 ·SLAS DISCOVERY ·María J. Vázquez,Stephen Ashman,Fernando Ramón,(unknown),Ana I. Bardera,J.J. Martin,Martin Rüdiger,David G. Tew,Juan Manuel Domı́nguez	6
6	The kinetic model of the shikimate pathway as a tool to optimize enzyme assays for high‐throughput screening 2006 ·Biotechnology and Bioengineering ·(unknown),(unknown),(unknown),Oleg Demin,David L. Earnshaw,Frank Tobin,Joshua M. West,John D. Martin,(unknown),Wu‐Schyong Liu,Walter E. DeWolf,David G. Tew,Igor Goryanin	17
7	Determination of phosphate in nanomolar range by an enzyme-coupling fluorescent method 2003 ·Analytical Biochemistry ·María J. Vázquez,(unknown),(unknown),David G. Tew	34
8	Cloning and Characterization of a Novel Human Dual Flavin Reductase 2000 ·Journal of Biological Chemistry ·Mark J. I. Paine,Andrew P. Garner,David J. Powell,(unknown),Mark Sales,Norman Pratt,(unknown),David G. Tew,C. Roland Wolf	75
9	N-1 substituted pyrimidin-4-ones: novel, orally active inhibitors of lipoprotein-associated phospholipase A2 2000 ·Bioorganic & Medicinal Chemistry Letters ·Helen Boyd,(unknown),(unknown),Deirdre M. B. Hickey,Robert J. Ife,Colin A. Leach,Colin H. Macphee,Kevin J. Milliner,Kitty Moores,Ivan L. Pinto,Rod A. Porter,(unknown),Stephen A. Smith,Ian Stansfield,David G. Tew,Colin J. Theobald,(unknown)	24
10	2-(Alkylthio)pyrimidin-4-ones as novel, reversible inhibitors of lipoprotein-associated phospholipase A2 2000 ·Bioorganic & Medicinal Chemistry Letters ·Helen Boyd,(unknown),(unknown),Robert J. Ife,(unknown),Colin A. Leach,Colin H. Macphee,Kevin J. Milliner,(unknown),Brian P. Slingsby,Stephen A. Smith,Ian Stansfield,David G. Tew,Colin J. Theobald	17
11	ASP1 (BACE2) Cleaves the Amyloid Precursor Protein at the β-Secretase Site 2000 ·Molecular and Cellular Neuroscience ·Ishrut Hussain,David J. Powell,David Howlett,Gayle A. Chapman,(unknown),Paul R. Murdock,David G. Tew,Thomas D. Meek,C.G. Chapman,Klaus Schneider,(unknown),Daniel Tattersall,(unknown),Christopher Southan,D. M. Ryan,David L. Simmons,F S Walsh,C. Dingwall,Gary Christie	131
12	Anti-atherosclerotic effect of SB-244323, a lipoprotein associated phospholipase A2 inhibitor, in WHHL rabbits 2000 ·Atherosclerosis ·G. Martin Benson,David C. Grimsditch,(unknown),Kitty Moores,Helen Boyd,David G. Tew,Deirdre M. B. Hickey,Robert J. Ife,Keith E. Suckling,Colin H. Macphee	12
13	Crystal structure of the FMN‐binding domain of human cytochrome P450 reductase at 1.93 Å resolution 1999 ·Protein Science ·Qiang Zhao,Sandeep Modi,Graeme C.M. Smith,Mark J. I. Paine,Paul McDonagh,C. Roland Wolf,David G. Tew,Lu‐Yun Lian,Gordon C. K. Roberts,H.P.C. Driessen	71
14	Inhibition of human cytomegalovirus protease by enedione derivatives of thieno[2,3-d]oxazinones through a novel dual acylation/alkylation mechanism 1999 ·Bioorganic & Medicinal Chemistry Letters ·Ivan L. Pinto,Richard L. Jarvest,Brian Clarke,Christine Dabrowski,Ashley Fenwick,M Gorczyca,L. J. JENNINGS,(unknown),E. J. Sternberg,David G. Tew,Andrew B. West	28
15	Nitric oxide synthases catalyze the activation of redox cycling and bioreductive anticancer agents. 1999 ·PubMed ·Andrew P. Garner,Mark J. I. Paine,Ignacio Rodríguez‐Crespo,E Chinje,Paul Ortiz de Montellano,Ian J. Stratford,David G. Tew,C. Roland Wolf	95
16	Benzothiopyran-4-one based reversible inhibitors of the human cytomegalovirus (HCMV) protease 1998 ·Bioorganic & Medicinal Chemistry Letters ·Dashyant Dhanak,Richard M. Keenan,George Burton,Arun C. Kaura,Michael G. Darcy,(unknown),Lance H. Ridgers,Ann Breen,(unknown),David G. Tew,Andrew B. West	42
17	Antioxidant effects of propofol in human hepatic microsomes: concentration effects and clinical relevance 1998 ·British Journal of Anaesthesia ·Yongping Bao,Gary Williamson,David G. Tew,Geoffrey W. Plumb,N. Lambert,J. G. Jones,David Menon	38
18	Napsins: new human aspartic proteinases 1998 ·FEBS Letters ·Peter J. Tatnell,David J. Powell,(unknown),(unknown),David G. Tew,John Kay	63
19	Crystallization and Preliminary X-Ray Diffraction Studies of Human Cytochrome P450 Reductase 1996 ·Journal of Structural Biology ·Qiang Zhao,Graeme C.M. Smith,Sandeep Modi,Mark J. I. Paine,C. Roland Wolf,David G. Tew,(unknown),William U. Primrose,Gordon C. K. Roberts,H.P.C. Driessen	6
20	Nitrogen-15 NMR studies of nitrosyl (bent and linear), nitro, and nitrito ligands in 4-, 5-, and 6-coordinate complexes of the platinum metals 1983 ·Inorganic Chemistry ·Linda K. Bell,Joan Mason,D. Michael P. Mingos,David G. Tew	43

About David G. Tew

David G. Tew is a scholar working on Molecular Medicine, Biochemistry and Electrochemistry, having authored 57 papers that have together received 4.2k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (6 papers), Pharmacogenetics and Drug Metabolism (4 papers) and Electrochemical Analysis and Applications (4 papers). The work is most often cited by research in Physiology (1.2k citations), Cancer Research (522 citations) and Pharmacology (523 citations). David G. Tew has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Valerie B. O’Donnell, Owen Jones, P. England, Christopher Southan, David J. Powell, P.R. Ortiz de Montellano, Thomas D. Meek, Colin H. Macphee, Israel Gloger and Helen Boyd. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact